Ceftobiprole medocaril sodium is a water-soluble prodrug ceftobiprole, a 5th-generation cephalosporin for the treatment of hospital-acquired pneumonia (excluding ventilator-associated pneumonia) and community-acquired pneumonia. Ceftobiprole binds to penicillin-binding proteins (PBPs) and inhibits their transpeptidase activity.